Infection with HIV-1 group O

AIDS Patient Care and STDs

Volumn 11, Issue 6, 1997, Pages 399-405

  Gould, Kenneth ^a  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; VIRUS STRAIN;

EID: 0031442943     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.1997.11.399     Document Type: Article

References (56)

1. Najera R, Herrera MI, de Andres R. AIDS - A Global Perspective - Human immunodeficiency virus and related retroviruses. West J Med 1987;147:702-708.
2. Hu DJ, Dondero TJ, Rayfield MA, George JR, Schochetman G, Jaffe HJ, Chi-Cheng L, Kalish ML, Weninger BG, Chou-Pong P, Schable CA, Curran JW. The emerging genetic diversity of HIV. JAMA 1996;275:210-216.
3. Louwagie J, McCutchan FE, Peeters M, Brennan TB, Sanders-Buell E, Eddy GA, van der Groen G, Fransen K, Gershy-Dament GM, Deleys R, Burke DS. Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS 1993;7:769-780.
4. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: Clinical and hematologic features of 16 cases. Blood 1977;50:481-492.
5. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci (USA) 1980;77:7415-7419.
6. Yoshida M, Miyoshi J, Hinumu Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci (USA) 1982;79:2031-2035.
7. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, De Thé G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985;2:407-410.
8. Osame M, Matsumoto M, Usuku K, Izumo S, Ijichi N, Amitani H, Tara M, Igata A. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type-1 and adult T-cell leukemia-like cells. Ann Neurol. 1987;21:117-122.
9. Marsh BJ. Infectious complications of human T cell leukemia/lymphoma virus type I infection. Clin Inf Dis 1996;3:138-145.
10. Kondo T, Nonaka H, Miyamoto N, Yoshida R, Matsue Y, Ohguchi Y, Inouye H, Komoda H, Hinuma Y, Hanaoka M. Incidence of adult T-cell leukemia-lymphoma and its familial clustering. Int J Cancer 1985;35:749-751.
11. Kaplan JE, Osame M, Kubota H, Igata A, Nishitani H, Maeda Y, Khabbaz RF, Janssen RS. The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immun Def Synd 1990;3:1096-1101.
12. Hinuma Y, Komoda H, Chosa T, Kondo T, Kohakura M, Takenaka T, Ichimaru M, Yunoki K, Yunoki K, Sato I, Matsuo R, Takiuchi Y, Uchino H, Hanaoka M. Antibodies to adult T-cell leukemia virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: A nation-wide sero-epidemiologic study. Int J Cancer 1982;29:631-635.
13. Lee HH, Swanson P, Rosenblatt JD, Chen IS, Sherwood WC, Smith DE, Tegtmeier GE, Fernando LP, Fang CT, Osame M, Kleinman SH. Relative prevalence and risk factors of HTLV-I and HTLV-II infection in U.S. blood donors. Lancet 1991;337:1435-1439.
14. Wachsman W, Golde DW, Chen ISY. HTLV and human leukemia: Perspectives 1986. Sem Hemat 1986;23:245-256.
15. Kushuhara K, Kajiyama W, Takahashi K, Tokugawa K, Fukushige J, Ueda K. Mother to child transmission of human T-cell leukemia virus type I (HTLV-I): a fifteen-year follow-up study in Okinawa, Japan. Int J Cancer 1987;40:755-757.
16. Takahashi K, Takezaki T, Oki T, Kawakami K,Yashiki J, Fujiyoshi T, Usuku K, Mueller N, Osame M, Miyata K, Nagata Y, Sonoda S. Inhibitory effect of maternal antibody on mother-to-child transmission of human T-lymphotropic virus type I. Int J Cancer 1991;49:673-677.
17. Kajiyama W, Kasyhiwaga S, Ikematsu H, Hayashi J, Nomura H, Okochi K. Intrafamilial transmission of adult T cell virus. J Infect Dis 1986;154:851-857.
18. Licensure of screening tests for antibody to human T-lymphotropic virus type I. Morbid Mortl Wkly Rep 1988;37:736-740, 745-747.
19. Hjelle B, Mills R, Swenson S, Mertz G, Kay C, Allen S. Incidence of hairy cell leukemia, mycosis fungoides and chronic lymphocytic leukemia in first known HTLV-II-endemic population. J Infect Dis 1991;163:435-440.
20. Hjelle B, Appenzeller O, Mills R, Alexander S, Torrez-Martinez N, Jahnke R, Ross G. Chronic neurode-generative disease associated with HTLV-II infection. Lancet 1992;339:645-646.
21. Lee HH, Weiss SH, Brown LS, Mildvan D, Shorty V, Saravolatz L, Chu A, Ginzburg HM, Markowitz N, Des Jarlais DC, Blattner WA, Allain JP. Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from middle Atlantic and central regions of the USA. J Infect Ms 1990;162:347-352.
22. Centers for Disease Control and Prevention and the U.S.P.H.S. Working Group Guidelines for counseling persons infected witt human T-lymphotropic virus type-I (HTLV-I) and type-II HTLV-II). Ann Int Med 1993;118:448-454.
23. Human T-lymphotropic virus type-I screening in volunteer blood donors - U.S., 1989 Morb Mortal Wkly Rep 1990;39:915, 921-924.
24. Ehrlich GD, Glaser JB, LaVigne K, Quan D, Mildvan D, Sninsky JJ, Kwok S, Papsidero L, Poiesz BJ. Prevalence of human T-cell leukemia/lymphoma virus (HTLV) type II infection among high risk individuals: type-specific of HTLVs by polymerase chain reaction. Blood 1989;74:1658-1664.
25. Wiktor SZ, Pate EJ, Weiss SH, Gohd RS, Correa P, Fontham ET, Hanchard B, Biggar RJ, Blattner WA. Sensitivity of HTLV-I antibody assays for HTLV-II (letter). Lancet 1991;338:512-513.
26. Pau CP, Thomas SL, Auwanit W, George JR, Ou CY, Parekh BS, Grenade TC, Holloman DL, Phillips S, Schochtetman G, Young NL, Takebe Y, Gayle HD, Weniger BG. Highly specific V3 peptide enzyme immunoassay for serotyping HIV-1 specimens from Thailand. AIDS 1993;7:337-340.
27. Soto-Ramirez LE, Renjifo B, McLane MF, Marlink R, O'Hara C, Sutthent R, Wasi C, Vithayassi P, Vithayassi V, Apichartpiyakul P, Auewarakul P, Cruz VP, Chui DS, Osathanondh R, Mayer K, Lee TH, Essex M. HIV-1 langerhans' cell tropism associated with heterosexual transmission of HIV. Science 1996;271:1291-1293.
28. Kanner SB, Parks ES, Scott GB, Parks WP. Simultaneous infections with Human T Cell type I and the Human Immunodeficiency virus. J Inf Dis 1987;155:617-424.
29. Briggs NC, Battjes RJ, Cantor KP, Blattner WA, Yellin FM, Wilson S, Ritz AL, Weiss SH, Goedert JJ. Seroprevalence of human t cell lymphotropic virus type II infection, with or without human immunodeficiency virus type 1 coinfection, among U.S. intravenous drug users. J Inf Dis 1995;172:51-58.
30. Baurmann H, Miclea JM, Ferchal F, Gessain A, Daniel MT, Guetard D, Collandre H, Agut H, Castaigne S, Rain JD, Montagnier L, Perol Y, Sigaux F, Degos L. Adult t-cell leukemia associated with HTLV-I and simultaneous infection by human immunodeficiency virus type 2 and human herpesvirus 6 in an African woman: a clinical, virologic, and familial serologic study. Am J Med 1988;85:853-857.
31. Rey F, Salaun D, Lesbordes JL, Gadelle S, Olivier-Henry F, Barré-Sinoussi F, Chermann JC, Georges AJ. HIV-1 and HIV-2 double infection in Central African Republic. Lancet 2:1391-1392, 1986.
32. Artenstein AW, CanCott TC, Mascola JR, Carr JK, Hejerich PA, Gaywee J, Sanders-Buell E, Robb ML, Dayoff DE, Thitivichianlert S. Dual infection with human immunodeficiency virus type 1 of distinct envelope subtypes in humans. J Inf Dis 1985;171:805-810.
33. Clavel F, Brun-Vézinet F, Guétard D, Chamaret S, Laurent A, Rouzioux C, Rey M, Katlama C, Rey F, Champelinaud JL. LAV type II: a second retrovirus associated with AIDS in West Africa. C R Acad Sci 1986;302:485-488.
34. Brun-Vézinet F, Katlama C, Roulot D, Lenoble L, Alizon M, Madjar JJ, Rey MA, Girard PM, Yeni P, Clavel F, Gadelle S, Harzic M. Lymphadenopathy-associated virus type 2 in AIDS-related complex. Lancet 1987;1:128-132.
35. De Cock KM, Adjorlolo G, Ekpini E, Sibailly T, Kouadio J, Maran M, Brattegaard K, Vetter KM, Doorly HD, Gayle HD. Epidemiology and transmission of HIV-2. JAMA 1993;270:2083-2086.
36. Guyader M, Emerman M, Sonigo P, Clavel F, Montagnier L, Alizon M. Genome organization and trans-activation of human immunodeficiency virus type 2. Nature 1987;326:662-669.
37. George JR, Rayfield MA, Phillips S, Heyward WL, Krebs JW, Odehouri K, Soudre R, De Cock KM, Schochetman G. Efficacies of US food and drug administration-licensed HIV-1-screening enzyme immunoassays for detecting antibodies to HIV-2. AIDS 1990;4:321-326.
38. Kloser PC, Mangia AJ, Leonard J, Lombardo JM, Michaels J, Denny TN, Sharer L, Sathe S, Weiss SH, Schable C, Horsburgh Jr. R, Oleske J, Kapila R. HIV2-associated AIDs in the United States. Arch Intern Med 1989;149:1875-1877.
39. Ayres L, Avillez F, Aarcia-Benito A, Deinhardt F, Gürtler DF, Ranger S, Grob, Joller-Jemelka H, Hess G, Seidl S, Flacke H, Simon F, Brun-Vézioet F, Sondag D, André A, Hampl H, Schoen R, Stramer S, Troonen H. Multicenter evaluation of a new recombinant enzyme immunoassay for the combined detection of antibody to HIV-1 and HIV-2. AIDS 1990;4:131-138.
40. De Leys R, Vanderborght B, Vanden Haesevelde M, Heyndrickx L, Van GEEI A, Wauters C, Bernaerts R, Saman E, Nijs P, Willems B, Taelman H, Van Der Groen G, Piot P, Tersmette T, Huisman JG, Van Heuverswyn H. Isolation and partial characterization of an unusual human immunodeficiency retoviras from two persons of West-Central. African origin. J Virol 1990;64:1207-1216.
41. Gürtler LG, Hauser PH, Eberle J, Von Brunn A, Knapp S, Zekeng L, Tsague JM, Kaptue L. A new subtype of human immunodeficiency virus type l (MVP-5180) from Cameroon. J Virol 1994;68:1581-1585.
42. Loussert-Ajaka I, Ly TD, Chaix ML, Ingrand D, Aragosti S, Couroucé AM, Brun-Vézinet F, Simon F. HIV-l/HIV-2 seronegativity in HIV-1 subtype O infected patients. Lancet 1994;343:1393-1394.
43. Identification of HIV-1 group O infection - Los Angeles County, California, 1996. Morbid Mortl Wkly Rep 1996;45:561-565.
44. Gould K, Britvan L, Dryjanski J. Report of a patient with HIV-1 group O infection in the United States. Lancet 1996;348:680-681.
45. Mulanga Kabeya C, Esu-Williams E, Eni E, Peetere M, Saman E, Delaporte E. Evidence for HIV-1 group O in Nigeria (letter). Lancet 1995;346:308.
46. Nkengasong JN, Peeters M, vanden Haesevelde M, Musi SS, Willems B, Ndumbe PM, Delaporte E, Peret JL, Piot P, van den Groen G. Antigenic evidence of the presence of the aberrant HIV-1 ANT70 virus in Cameroon and Gabon. AIDS 1993;7:1536-1538.
47. Peeters M, Gaye A, Mboup S, Badombena W, Bassabi K, Prince-David M, Develoux M, Liegeois F, van der Groen G, Saman E, Delaporte E. Presence of HIV-1 group O in West Africa. AIDS 1996;10:343-343.
48. Zekeng I, Gürtler L, Afnae ZE E, Sam-Abbenyi S, Mbouni-Essomba G, Mpoudi-Ngolle E, Monny-Lobe M, Tapko JB, Kaptae L. Prevalence of HIV-1 subtype O infection in Cameroon: preliminary results. AIDS 1994;8:1626-1628.
49. Pau CP, Hu DJ, Spruill C, Schable C, Lackritz E, Kai M, George JR, Rayfield MA, Dondero TJ, Williams AE, Busch MP, Brown AE, McCutcheon FE, Schchetman G. Surveillance for HIV-1 group O infections in the United States. Transfusion 1996;36:398-400.
50. Clewey JP, Arnold C, Barlow KL, Grant PR, Parry JV. Diverse HIV-1 genetic subtypes in UK. Lancet 1996;347:1487.
51. Rare HIV-1 strains more prevalent in United States. AIDS Alert 1996;11:103-105.
52. Schable C, Zekeng L, Pau CP, Hu D, Kaptue L, Gürtler L, Dondero T, Teague JM, Schochetman G, Jaffe H, George JR. Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections. Lancet 1994;344:1333-1334.
53. Simon F, Ly TD, Baillou-Beaufils A, Faureau V, De Saintmartin J, Loussert-Ajaka I, Chaix ML, Saragosti S, Couroucé AM, Inland D, Janos C, Brun-Vézinet F. Sensitivity of screening kits for anti-HIV-1 subtype O antibodies. AIDS 1994;8:1628-1629.
54. Dondero TJ, Hu DJ, George JR. HIV-1 variants: yet another challenge to public health. Lancet 1994;343:1376.
55. Gürtler LG, Zekeng L, Simon F, Eberle J, Tsague JM, Kaptue L, Brust S, Knapp S, Reactivity of five anti-HIV-1 subtype O specimens with six different anti-HIV screening ELlSAs and three immunoblots. J Viral Meth 1995;51:177-184.
56. Persistent lack of detectable HIV-1 antibody in a person with HIV infection - Utah 1995. Morb Mort Wkly Rep 1996;45:181-185.